Loading...
•
Dec 31, 2023
Select Medical Q4 2023 Earnings Report
Announced results for the fourth quarter and year ended December 31, 2023 and declared a cash dividend.
Key Takeaways
Select Medical Holdings Corporation reported a 4.9% increase in revenue to $1,658.9 million for the fourth quarter ended December 31, 2023. Net income increased 63.9% to $61.8 million, and earnings per common share increased 63.6% to $0.36.
Revenue increased by 4.9% to $1,658.9 million compared to the same quarter last year.
Income from operations increased by 31.5% to $114.3 million compared to the same quarter last year.
Net income increased by 63.9% to $61.8 million compared to the same quarter last year.
Earnings per common share increased by 63.6% to $0.36 compared to the same quarter last year.
Revenue by Segment
Forward Guidance
Select Medical expects revenue to be in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA to be in the range of $830 million to $880 million, and fully diluted earnings per share to be in the range of $1.88 to $2.18 for 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...